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Available online 30 November 2010Abstract Background The authors presented their experience in regenerative surgery of post-traumatic lower extremity
ulcers, evaluating the effects related to the use of Enhanced Stromal Vascular Fraction (e-SVF) and Fat Grafting with Platelet
rich Plasma (PRP). The authors compared the results of two control groups.
Method The analysis involved 20 patients aged between 23 to 62 years affected by post-traumatic lower extremity ulcers. 10
patients managed with e-SVF and 10 patients managed with Fat grafting+PRP in the Plastic and Reconstructive Surgery
Department at “Tor Vergata” University Rome. Patients in the first control group (n=10), were treated only with curettage and
application of hyaluronic acid in the bed of ulcers. Patients in the second control group (n=10), were treated only with PRP.
Results The authors showed that wounds treated with e-SVF healed better than those treated with hyaluronic acid. In fact,
after 9.7 weeks, patients treated with e-SVF underwent 97.9%±1.5% reepithelialisation compared to 87.8%±4.4% of the first
control group (only hyaluronic acid; pb0.05). Patients treated with PRP and fat grafting also showed an improvement in
reepithelialisation; in fact after 9.7 weeks, they underwent a 97.8%±1.5% reepithelialisation compared to 89.1%±3.8% of the
second control group (only PRP; pb0.05). As reported e-SVF and PRP mixed with fat grafting were the two treatments
evidencing improvement in the healing of patients post-traumatic extremity ulcers.
Conclusions The results obtained proved the efficacy of these treatments, and the satisfaction of the patients confirmed the
quality of the results.
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The authors have already published the results obtained from
using of Platelet Rich Plasma (PRP) mixed with fat grafting in
the treatment of chronic-lower extremity ulcers [11,18] and
loss of substance on the lower limbs [17]. Their subsequent
research suggests a new therapeutic plan: the use of
Enhanced Stromal Vascular Fraction (e-SVF). The presenta-
tion of clinical cases has shown that application of e-SVF can
improve tissue healing. Improvement was reached through
increased vascularization the secretion of growth factors
improving tissue survival. e-SVF was extracted from patient's
adipose tissue at the bedside using the Celution™ System.
With this technology, this cell population were separated
from adipocytes and extracellular matrix by enzymatic
digestion and centrifugation. Consisting of a heterogeneous
cell population they include endothelial cells, endothelial
progenitor cells, smooth muscle cells, pericytes, macro-
phages and blood derived cells as well as multipotent
Enhanced Stromal Vascular Fraction (e-SVF) [7,15]. The
results achieved from this study also indicate the efficacy of
the two treatments. The quality and potency of the results
were confirmed by the patient satisfaction. The new
therapeutic plan differs from conservative treatment that
included elevation, skin grafting, local treatment (biosyn-
thetic material), Vac (vacuum) therapy, from current
available alternatives such as autologous skin (harvest,
graft), skin from a bank (autologous, taken from cadaveric
or living subjects), engineered skin (autologous expanded in
vitro), and biosynthetic materials.Figure 1 (A) Fat harvest; (B) intra-operative during peri-lesional
injection (only e-SVF); (D) medication with hyaluronic acid.Results
Influence of e-SVF in tissue regenerationThe authors results showed that patients’ wounds (Figs. 2A
and 3A) treated with e-SVF healed better (Fig. 2B)
than wounds treated with hyaluronic acid. In fact, after
9.7 weeks (Figs. 2C and 3B), the patients treated with
e-SVF underwent a 97.9%±1.5% reepithelialisation compared
to 87.8%±4.4% of 1st control group (hyaluronic acid
only; pb0.05). Patients treated with PRP and Lipostructure
also showed an improvement in reepithelialisation; in
fact after 9.7 weeks, they underwent a 97.8%±1.5% ree-
pithelialisation compared to 89.1%±3.8% of 2nd control
group (PRP only; pb0.05). As reported e-SVF and PRP mixed
with fat grafting were the two treatments that showed
improvement in the healing process in post-traumatic
extremity ulcers.
The authors reported clinical results in Tables 1 and 2 and
observation of diameter lesion in Table 3.Stromal Vascular Fraction nucleated cells from
automatic and manual extraction
From adipose tissue, by manual extraction, we obtained
about 250,000 (±) 34,782 nucleated cells/ml of fat tissue,
instead by the automatic extractor, cell yield was about
50,000 (±) 6,956 nucleated cells/ ml of fat tissue (pb0.01).injection (Fat+e-SVF); (C) surgical procedure of intra-lesional
Figure 2 (A) pre-operative in lateral right; (B) post-operative -1 week- in lateral right after treatment based on perilesional
injection of Fat+e-SVF and intra-lesional injection of only eSVF; (C) postoperative after 9.7 week, in lateral right.
105Stromal vascular fraction and fat grafting mixed with PRP in posttraumatic lower extremity ulcersHistopathological evaluation
Microscopic evaluation showed a progressive process of ulcer
re-epithelialization, starting from a typical fibrin clot forma-
tion in biopsies taken at baseline (Fig. 4A), proceeding through
the formation of dermal granulation tissue rich in newly
deposed vessels with overlying early migration of cheratino-
cytes at week 3 (Fig. 4B), followed by the appearance of
reactive epidermal hyperplasia at week 7 (Fig. 4C), and finally
resulting in complete re-epithelialization with newly deposed
dermal collagen (Fig. 4D).Figure 3 (A) pre-operative in back projection; (B) post-operat
perilesional injection of Fat+e-SVF and intra-lesional injection of onDiscussion
New techniques in tissue regeneration are mostly explained
in literature, but there are no articles concerning the
possible use of e-SVF either by direct injection into the bed
of the ulcers or injecting it in the perilesional area mixed fat
graft.
The potential benefit of e-SVF supplementation could be
explained by the ability of cells, which exist within the e-SVF
population [2], to secrete various growth factors that
improve survival and increased vascularization [3,4] leadingive -9.7 week- in back projection after treatment based on
ly e-SVF.
Table 1 A Patients, affected by post-traumatic lower-extremity ulcers treated with SVF-enhanced autologous fat grafts,
obtained by Celution System; 1B Patients, affected by post-traumatic lower-extremity ulcers treated with fat grafting based on
Coleman technique mixed with PRP
Pz Age Co-morbidity Patology Old treatment Treatment Complication
A
1 42 No Post- traumatic lower extremity ulcers Wound complex Fat graft (Celution) No
2 34 No Post-traumatic lower extremity ulcers Toilette+wound complex Fat graft (Celution) No
3 40 No Post-traumatic lower extremity ulcers Wound complex Fat graft (Celution) No
4 29 No Post-traumatic lower extremity ulcer Amputation Fat graft (Celution) ematoma
5 37 Dislipidemy Post-traumatic lower extremity ulcers Toilette+wound complex Fat graft (Celution) No
6 39 No Post-traumatic lower extremity ulcers Wound complex Fat graft (Celution) No
7 35 Ipertension Post-traumatic lower extremity ulcers Toilette+wound complex Fat graft (Celution) No
8 56 No Post-traumatic lower extremity ulcers Wound complex Fat graft (Celution) No
9 51 Cardiological
disease
Post-traumatic lower extremity ulcers Toilette+wound complex Fat graft (Celution) No
10 60 No Post-traumatic lower extremity ulcers Wound complex Fat graft (Celution) No
B
1 46 No Skin depression+post-traumatic wound No Lipostructure+PRP No
2 23 No Post-traumatic ulcers No Lipostructure+PRP No
3 41 No Post-traumatic foot ulcers No Lipostructure+PRP No
4 62 No Skin depression No Lipostructure+PRP No
5 37 Ipertension Post-traumatic lower extremity wound No Lipostructure+PRP No
6 32 No Post-traumatic wound No Lipostructure+PRP No
7 34 No Post-traumatic wound No Lipostructure+PRP No
8 42 Ipertension Post-traumatic skin depression+Ulcers No Lipostructure+PRP No
9 36 No Post-traumatic lower extremity ulcers No Lipostructure+PRP No
10 35 No Post-traumatic lower extremity ulcers No Lipostructure+PRP No
106 V. Cervelli et al.to an increased survival of the graft as shown by a study on
a rodent [5]. In this work we analyzed the SVF cellular
content from the automatic system, since we previously
did it for the manual extraction used in our in vitro studies
(Cervelli et al 2009). Our results documented that the
SVF cell yield from the manual system was much more
efficient than the automatic system. It would be necessary
to have further informations about automatic system
operation to explain this finding. We hypothesize that the
mechanism of regeneration of the tissue is the following:
targeting of damaged areas, release of angiogenic and
antiapoptotic factors followed by formation of new vessels
and oxygenation.
Implanted adipose tissue must survive by a simple
diffusion mechanism until an active blood supply is re-
established. Thus survival of the graft, particularly of a
larger volume graft, is balanced between this process and
hypoxia-induced cell death [1,6]. Pro-survival factors may
therefore promote.
long term retention and consequently durability of
the graft. In an animal study, this effect was achieved by
using gene therapy to deliver Vascular Endothelial Growth
Factor (VEGF; a potent pro-angiogenic factor) to the
graft. This resulted in increased blood vessel density within
the graft and a significant improvement in graft retention
at 15 weeks [7]. Neo-angiogenesis was also confirmed
from an histopathologically point of view highlightingthe abundance in capillaries sprout within the healing
tissue, leading to a complete re-epithelialization of the
ulcers.
e-SVF can favour neo-angiogenic vascularization and
fibrogenic activity of fibroblasts that favour adipose tissue
survival and three-dimensional organization. Compared to
traditional fat grafting, the survival of the graft is more
probable and fat necrosis is potentially reduced due to
improved vascular development in the implanted area.
Results of this study offer an in vivo tissue-engineering
approach that provides an optimized microenvironment,
supporting the correct architectural adipocyte distribution,
better cell-to-cell interaction, adipose tissue survival, and
maybe limited differentiation from e-SVF; this could offer
early protection from surrounding inflammatory events.
The early establishment of new micro capillary networks
and the proper deliver of nutrients and oxygen to the
implant may contribute to the improved outcomes observed
[8,9].
Our clinical study clearly documented that e-SVF im-
proved skin ulcer reepithelialisation in patients who under-
went regenerative surgery. Moreover, e-SVF improved
maintenance and function of adipose tissue graft. The
authors, having a significant experience with Platelet Rich
Plasma mixed fat grafting, compared the results of the
clinical study. In fact, platelet-rich plasma was used for
lower extremity ulcers, demonstrating that the use of PRP
Table 2 A The first control group treated with curettage and hyaluronic acid; 2B the 2nd control group treated with only PRP




1 59 Dislipidemy Post-traumatic Foot ulcer Toilette Wound complex Edema, Infection
2 47 No Post-traumatic Foot ulcer No Wound complex No
3 43 No Post-traumatic Foot ulcer Toilette Wound complex No
4 54 Dislipidemy Post traumatic Foot ulcer Toilette Wound complex Infection
5 62 Ipertension Post-traumatic Lower extremity ulcers Toilette Wound complex No
6 49 Cardiological disease Post-traumatic Lower extremity ulcer Amputation Wound complex No
7 54 Cardiological disease Post-traumatic Lower extremity ulcer Toilette Wound complex Edema,
Ematoma, Infection
8 44 No Post traumatic Foot ulcer No Wound complex No
9 31 Arteriopaty lower extremity Post traumatic Foot ulcer No Wound complex No




1 45 Ipertension Post-traumatic Foot ulcer Toilette PRP Edema
2 33 No Post-traumatic Foot ulcer No PRP No
3 37 Dislipidemy Post-traumatic Foot ulcer Toilette PRP No
4 60 Trauma Post traumatic Foot ulcer Toilette PRP Ematoma
5 61 No Post-traumatic Lower extremity ulcers Toilette PRP No
6 29 Arteriopaty lower extremity Post-traumatic Lower extremity ulcer Amputation PRP No
7 35 Cardiological disease Post-traumatic Lower extremity ulcer Toilette PRP Edema, Ematoma
8 40 No Post traumatic Foot ulcer No PRP No
9 43 No Post traumatic Foot ulcer No PRP No
10 23 No Post traumatic Foot Ulcer N°1 Vacuum
therapy
PRP No
107Stromal vascular fraction and fat grafting mixed with PRP in posttraumatic lower extremity ulcerscombined with fat tissue resulted in numerous advantages
[10,11]. The authors in the treatment with PRP used an
average of 0.3-0.5 ml of activated platelet gel combined
with 1 ml of centrifuged fat tissue. Platelet gel is a mixture
of autologous proteins [12,13] that contains from 300,000 to
350,000 platelets, which once injected stimulate skin
fibroblast.
This mixture favour tissue growth by a new synthesis of
collagen. During the wound-healing process (4 phases:
haemostasis, inflammation, proliferation, and re-modelling),
platelet growth factors serve asmessengers to regulate awell-
orchestrated and complex series of events involving cell–cell
and cell–matrix interactions that promote the proliferation
of mesenchymal and other stem cells at the wound site
[14]. The authors, on the basis of this concept, have added
fat grafting to PRP. Autologous platelet-derived wound-
healing factors were proposed to regulate wound healing of
chronic ulcers bypromoting the formation of granulation tissue
in the early healing phase. Alternatively, the authors used
conservative treatment that included elevation, skin grafting,
local treatment (biosynthetic material), and Vac (vacuum)
therapy.
The current available alternatives for treating ulcers are
autologous skin (harvest, graft), skin from a bank (autolo-
gous, taken from cadaveric or living subjects), engineered
skin (autologous expanded in vitro), and biosynthetic
materials.The results proved the efficacy of these two new
treatments (e-SVF and PRP).Material and methods
Patients
A total of 20 patients were treated at the Plastic and
Reconstructive Surgery Department of “Tor Vergata” Uni-
versity, Rome.
10 patients (5 female and 5 male), aged between 29 and
60 years (Table 1A), affected by post-traumatic lower-
extremity ulcers were treated with SVF-enhanced autologous
fat grafts, obtained by Celution System. The patients were
subjected to additional wash and centrifugation cycles, after
which 5 ml of the e-SVF suspension was extracted from the
system. The medical process continued by dividing the 5 ml of
e-SVF into two equal parts. The first half of e-SVF (2,5 ml) was
added to the tissue collection container with the liposuction.
Subsequent to the carrying out of a washing step, the e-SVF
suspension was added and mixed with the washed fat
graft. Using specific micro-cannulas for implantation the
SVF-enhanced fat graft was transferred into 10 ml syringes
and aseptically re-injected into the perilesional area. The
remaining part was injected into the bed of ulcer after
curettage.
Table 3 A Diameter of the lesion in the patients treated
with e-SVF; 3B diameter of the lesion in the patients
treated with fat grafting mixed with PRP; 3C diameter of
the lesion in the patients treated with hyaluronic acid; 3D


















Pz 1 4,7 4,1 3.8 3,0 2,7 0 0
Pz 2 7,3 6,3 5,8 5.1 4,6 0.5 0
Pz 3 3,8 3,5 3.0 2.8 2,2 0 0
Pz 4 5.6 5.3 5,0 4,8 4,1 0.77 0
Pz 5 4,1 3,5 3.1 2,0 1,1 0 0
Pz 6 4,3 3,7 3.3 2.4 1,5 0 0
Pz 7 4,3 3,9 3,4 2,8 2,0 0 0
Pz 8 7,5 7,2 6,8 5,9 5,0 0 0
Pz 9 5,1 4,7 4,2 3,4 2,4 0 0
Pz 10 6,2 5,8 5,3 4,5 3,7 0 0
B
Pz 1 7,1 6,9 6,2 4,1 1,1 0,6 0
Pz 2 3,6 3,3 2,7 1,6 0 0 0
Pz 3 5,9 5,5 4,9 2,7 0 0 0
Pz 4 7.2 6,9 6,4 5,3 1,4 0 0
Pz 5 4,5 4.3 3,9 2,1 0 0 0
Pz 6 6,3 6,1 5,8 2,6 0 0 0
Pz 7 3,3 3,0 2,7 1,4 0 0 0
Pz 8 4,2 3,9 2,3 1,5 0 0 0
Pz 9 5,1 5,0 4,5 4,2 2,1 0,7 0
Pz 10 3,8 3,6 3,1 2,6 1,4 0 0
C
Pz 1 6,8 6,8 6,5 5,8 4,0 2,8 1,2
Pz 2 3,9 3,9 3,5 2,7 0,9 0 0
Pz 3 6,2 6,2 5,9 5,0 3,4 1,3 0,2
Pz 4 7.0 7,0 6,7 5,9 3,6 1,6 0,4
Pz 5 4,9 4.9 4,5 3,6 1,2 0 0
Pz 6 6,0 6,0 5,7 4,9 2,5 0,8 0
Pz 7 3,0 3,0 2,7 1,9 0,4 0 0
Pz 8 3,9 3,9 3,5 2,7 1,0 0 0
Pz 9 4,8 4,8 4,5 3,7 2,1 0,9 0
Pz 10 4,0 4,0 3,6 2,8 1,2 0,2 0
D
Pz 1 5,4 5,4 5,0 4,6 2,3 1,0 0
Pz 2 4,3 4,3 3,9 3,4 1,4 0 0
Pz 3 5,1 5,1 4,7 4,3 2,1 0,3 0
Pz 4 6.3 6.3 5,9 5,5 3,4 1,9 0,3
Pz 5 5,1 5,1 4,7 4,3 2,3 1,1 0
Pz 6 6,5 6,5 6,1 5,4 3,3 1,7 0,2
Pz 7 3,7 3,7 3,3 2,9 1,0 0 0
Pz 8 4,5 4,5 4,1 3,8 1,9 0.3 0
Pz 9 4,1 4,1 3,7 3,4 1,3 0 0
Pz 10 4,9 4,9 4,5 4,1 2,0 0 0
108 V. Cervelli et al.10 patients (Table 1B) 5 female and 5 male aged between
23 and 62 years affected by post-traumatic lower extremity
ulcers were treated with fat grafting based on Coleman
technique mixed with PRP. The purified fat was obtained
after centrifugation at 3000 RPM and placed in 1 ml syringes,
therefore aseptically reinserted using specific micro –
cannulas for implanting. The 1 ml of fat centrifuged tissue
was also mixed by the authors with 0.3-0.5 average ml of
PRP. The selection of location destined to receive the
implant was determined taking into account the diversity in
the lesions. The harvested material was implanted into the
lower extremity ulcers of the perilesional area. In order to
implant the fat tissue, small tunnels were previously created
forcing the cannulas of 1.5 mm diameter with accurate and
controlled movements. Once the fat tissue had been
implanted at different levels the access incisions were
closed using 5-0 nylon stitches and no compressive bandage
was applied.
This study is part of a research project approved by Tor
Vergata.Control groups
In order to establish the effects of their treatment, the
authors compared their results with two control groups each
made up of 10 patients.
The authors considered exclusion criteria. Exclusion
criteria were divided in two types: local and systemic.
The systemic criteria include: platelet disorders, thrombo-
cytopenia, anti aggregating therapy, bone marrow aplasia,
uncompensated diabetes, sepsis and cancer. The local
criteria include: osteomyelitis, loss of substance of more
than 50% of the segments. The authors was not considered
exclusion criteria tobacco use and genetic disorders.
The first control group (Table 2A) comprised 5 females
and 5 males aged between 23 and 62 years all affected by
post-traumatic lower extremity ulcers. This sample group
was treated with curettage and application of hyaluronic
acid in the bed of the ulcers. The medication based on
hyaluronic acid where removed from the authors after
15 days.
The second control group (Table 2B) comprised the same
characteristics of the first (number of people, age and type
of ulcers), however patients underwent a different treat-
ment. They received only PRP.
The PRP was obtained using 18 ml of blood from a
peripheral venous access collected in two sterile 9-ml
tubes. The blood was extracted using the Cascade Kit and
subjected to centrifuging for 10 min at 1,100 g [10,11].
After centrifugation, the two tubes of inactivated
PRP were switched with two 10-ml tubes containing CaCl
[10,11].
From this point, after the addition of CaCl (which
determined the activation of PRP), the two tubes obtained
were centrifuged for 15 min at 1,100 g. A product with
increased consistency was obtained.
This sample group was treated with curettage and it
was applied to it only PRP obtained in the bed of the ulcers.
The bed of the ulcer contained the PRP solid gel fixed with
nylon.
Figure 4 Histopathological findings of leg chronic ulcer before, during and after treatment by e-SVF. (A) Baseline evaluation of a
skin punch biopsy revealing the typical fibrin clot with cellular debris and dermal inflammatory infiltrate rich in neutrophils; (B) At
week 3, formation of dermal granulation tissue, rich in newly formed vessels, along with chronic inflammatory infiltrate, with
overlying initial migration of cheratinocytes starting to re-epithelize the defect; (C) At week 7, regenerative skin with reactive
epidermal hyperplasia with underlying chronic lymphomonocytic infiltrate, abundant capillaries sprout and fibroblasts; (D) After
treatment, at week 16, complete healing with re-epithelialization and newly deposed dermal collagen. (Hematoxylin and eosin stain.
Original magnification, A-D: x100).
109Stromal vascular fraction and fat grafting mixed with PRP in posttraumatic lower extremity ulcersHarvest region and preparation of the SVF-enhanced
autologous fat graftA solution based on 1 fl of adrenalin in 500 cc of cold
physiological solution was injected into the abdominal region
of the patients treated with e-SVF. The cell and tissue
preparation procedure was a two phases process. In first
phase the abdominal region of each using 3 mm cannulas of
an average of 400 ml of liposuction (Fig. 1 A). Maintaining on
aseptic technique, the plunger of the 60 ml-syringe was
removed and the tip was closed with a cap. Half of the
liposuction (200 ml average) was placed into the tissue
collection container of the Celution™ 800/CRS System (Cytori
Therapeutics Inc., USA). A wash cycle removed blood and
free lipid from the tissue and the Celase™ 835/CRS Reagent
was added in order to enzymatically digest the tissue which
released e-SVF. After additional wash and centrifugation
cycles, 5 ml of the e-SVF suspension was extracted from the
system.
Having completed the first steps the treatment, the
authors divided e-SVF suspension in to two equal parts. In
phase one of the study, the first aliquot of suspension
containing e-SVF (2.5 ml) was injected directly into the bed
of the ulcer (Fig. 1C).In the second phase, the remaining 200 ml of liposuction
was added to the tissue collection container and a washing
step was carried out. Once completed, the remaining aliquot
of the previous division of e-SVF suspension was added and
mixed with the washed fat graft, resulting in approximately
170 ml of SVF-enhanced fat tissue for grafting. This newly
processed cell-enhanced fat graft typically consisting of
25%-30% of water which will be reabsorbed by the body in the
post-operative period. This overall process is controlled
through automated sensors and processing algorithms ensur-
ing standard handling of the tissue and cells the process
is completed within 160 minutes. The SVF-enhanced fat
graft was transferred into 10 ml syringes and aseptically
re-injected in the perilesional area (Fig. 1B) using specific-
micro-cannulas for implantation.Surgical technique and location of implantation
The authors injected the SVF-enhanced adipose tissue
usingspecific micro-cannulas (1-2 mm in diameter) for
implantation.
The area destined to receive the graft was determined
based on the necessary selection of a perilesional graft or
an intra-lesional application or both. Subsequently, the
110 V. Cervelli et al.authors applied to the post-traumatic lower extremity
ulcers the first quantity (2.5 ml ) of the e-SVF suspension
directly into the ulcer bed. A medication based on hyaluronic
acid was then fixed applying a 3-0 nylon at the margins and a
superior silicon substrate (Fig. 1D). The other remaining
aliquot of e-SVF suspension, was mixed with fat graft
and injected into the perilesional area at the subcutaneous
tissue level. The substrate was removed after 8 days, the
medication was removed after 16 days. After pre-tunnel, fat
tissue was implanted at different levels using a delivery
cannula (1-2 mm in diameter) with precise, controlled
movements. While using the cannula small quantities of e-
SVF enhanced fat graft were injected to create a large grid,
thus increasing the probability of transplanted tissue
survival. Several layers were laid down to increase the
contact surface between the receiving tissue and the
implant. This technique is of fundamental importance: it
allows each layer deposited to survive by diffusion during the
few days necessary for growth of blood vessels which will
nourish the implant permanently. The incisions were closed
with 5-0 nylon suture and no compressive bandage was
applied.
Clinical evaluation methods
Through the analysis of pre-operative and post-operative
photos, the authors were able to evaluate the tissue
regeneration. The sample photos taken into account were
of the same size, brightness and with the same contrast
to facilitate comparison. In fact, operators were able
to calculate the percentage of wound healed. Finally, the
mean between patient and operator evaluation was
made. To evaluate the healing rate of skin chronic ulcer
used the method of Kazakos [16] with minor modifications.
This process comprises a further division of the patients
in four groups each of which differentiate in treatment.
The first group reunited the patients treated with e-SVF,
the second included also together the patients treated
with fat grafting mixed with PRP. The third group reunited
the patients treated with hyaluronic acid and the fourth
included the patients treated with PRP. Finally, the change
of wound surface area (2 cm) was calculated on a weekly
basis.
Stromal Vascular Fraction nucleated cells isolation and
counting
For manual SVF extraction, liposuction aspirates were
washed three times with phosphate-buffered saline (PBS)
and suspended in an equal volume of PBS and 0.1%
collagenase type I (C130; Sigma-Aldrich, Milan, Italy) pre-
warmed to 37 °C. Adipose tissue was placed in a shaking
water bath at 37 °C with continuous agitation for 60 min and
centrifuged for 10 min at 600 g at room temperature. The
supernatant, containing mature adipocytes, was aspirated.
The SVF pellet was resuspended in erythrocyte lysis buffer
(155 mM NH4Cl, 10 mM KHCO3, and 0.1 mM EDTA) and
incubated for 5 min at room temperature. After centrifuga-
tion at 1100RPM for 5 min, the pellet was resuspended in few
micro-litres of growth medium and passed through a 100-mm
Falcon strainer (Becton and Dickinson, Sunnyvale, CA) andcellular population was counted using hemocytometer. For
automatic SVF extraction the Celution® System was used.
After centrifugation of fat inserted in the system for two
hours a 5 ml ringer solution was obtained containing Stromal
Vascular Fraction Cells. SVF pellet was resuspended in
erythrocyte lysis buffer and cellular population was counted
as described above. After centrifugation at 1100RPM for
5 min, the pellet was resuspended in a few micro liters of
growth medium and cellular population was counted using
hemocytometer.
Histopathological evaluation
Incisional punch biopsies (3 mm in diameter) at the level
of the ulcers were obtained from a small sample of patients
at baseline, week 3, week 7 and week 16. Microscopic
evaluation of routinary hematoxylin-eosin stained paraffin-
derived sections was performed to morphologically verify
the healing process of the ulcers treated by e-SVF.
Statistical analysis
Values are shown asmean plus standard error of mean (s.e.m).
Results were analyzed by means of Students t-test, and
differences considered statistically significant for pb0.05.References
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